Mouse Anti-DLX4 Recombinant Antibody (7C8) (V2LY-0425-LY525)

Sun, G., Ge, Y., Zhang, Y., Yan, L., Wu, X., Ouyang, W., ... & Ye, Z. (2021). Transcription Factors BARX1 and DLX4 Contribute to Progression of Clear Cell Renal Cell Carcinoma via Promoting Proliferation and Epithelial–Mesenchymal Transition. Frontiers in molecular biosciences, 8, 453.

Ling, Z., Long, X., Li, J., & Feng, M. (2020). Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up‐regulation of YB‐1. Genes to Cells, 25(7), 466-474.

Zhang, L., Wan, Y., Jiang, Y., Zhang, Z., Shu, S., Cheng, W., & Lang, J. (2019). Overexpression of BP1, an isoform of Homeobox Gene DLX4, promotes cell proliferation, migration and predicts poor prognosis in endometrial cancer. Gene, 707, 216-223.

Bhattacharya, S., Duverger, O., Brooks, S. R., & Morasso, M. I. (2018). Homeobox transcription factor DLX 4 is not necessary for skin development and homeostasis. Experimental dermatology, 27(3), 289-292.

Jeong, J., Naab, T. J., Fernandez, A. I., Ongkeko, M. S., Makambi, K. H., & Blancato, J. K. (2018). Homeoprotein DLX4 expression is increased in inflammatory breast cancer cases from an urban African-American population. Oncotarget, 9(58), 31253.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols